Clinical Characteristics and Outcome in Patients with Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State Associated with COVID-19: A Retrospective, Hospital-Based Observational Case Series

Hoe Chan K, Thimmareddygari D, Ramahi A, Atallah L, Baranetsky NG, Slim J.

Diabetes and COVID-19: IDF perspective in the Western Pacific Region

Hwang Y, Khasag A, Jia W, Jenkins A, Huang CN, Yabe D, Kim DM, Kadowaki T, Lee MK.

A proposed mechanism for the possible therapeutic potential of Metformin in COVID-19

Esam Z.

COVID 19 and low-glucose levels : is there a link ?

Piarulli F, Lapolla A.

COVID-19 and Diabetes from IDF MENA Region

Belkhadir J, Al.

Well-controlled vs Poorly-controlled Diabetes in Patients with COVID-19: Are There Any Differences in Outcomes and Imaging Findings?

Raoufi M, Khalili S, Mansouri M, Mahdavi A, Khalili N.

H(ome)bA1c Testing and Telemedicine: High Satisfaction of People with Diabetes for Diabetes Management During COVID-19 Lockdown

Kanc K, Komel J, Kos M, Wagner J.

Sedentariness and Physical Activity in Type 2 Diabetes mellitus during the COVID-19 Pandemic

Balducci S, Coccia EM.

Potential role of incretins in diabetes and COVID-19 infection: a hypothesis worth exploring

Pantanetti P, Cangelosi G, Ambrosio G.

Successful blood glucose management of a severe COVID-19 patient with diabetes: A case report

Hu R, Gao H, Huang D, Jiang D, Chen F, Fu B, Yuan X, Li J, Jiang Z.

COVID-19 and Type 1 Diabetes: Challenges and actions

Klatman EL, Besancon S, Bahendeka S, Mayige M, Ogle GD.

Unexpected high mortality in COVID-19 and diabetic ketoacidosis

Chamorro-Pareja N, Parthasarathy S, Annam J, Hoffman J, Coyle C, Kishore P.

Impaired glucose metabolism in patients with diabetes, prediabetes and obesity is associated with severe Covid-19

Smith SM, Boppana A, Traupman JA, Unson E, Maddock DA, Chao K, Dobesh DP, Brufsky A, Connor RI.

Corticosteroids in diabetes patients infected with COVID-19

Deng F, Gao D, Ma X, Guo Y, Wang R, Jiang W, Gong S.

Diabetes management during Ramadan amid Covid-19 pandemic

Tootee A, Esfahani EN, Larijani B.

A Significance of High Prevalence of Diabetes and Hypertension in Severe COVID-19 Patients

Yanai H.

Diagnosis of gestational diabetes during the pandemic: what is the risk of falling through the net?

Ikomi A, Mannan S, Simon G, Khan R, Smith S, Robbins J, Kavanagh U, Crone D.

Diabetes, Infection Risk And Covid-19

Erener S.

Challenges of diabetes management during the COVID-19 pandemic

Scott ES, Jenkins AJ, Fulcher GR.

Diabetes increases the mortality of patients with COVID-19: a meta-analysis

Wu ZH, Tang Y, Cheng Q.

People with Diabetes Mellitus: Soft target for COVID-19 infection

Hussain A, Ali I, Hassan Z.

Adrenal Vascular Changes in COVID-19 Autopsies

Iuga AC, Marboe CC, Yilmaz MM, Lefkowitch JH, Gauran C, Lagana SM.

Detecting SARS-CoV-2 RNA in conjunctival secretions: is it a valuable diagnostic method of COVID-19?

Güemes-Villahoz N, Burgos-Blasco B, Vilela AA, Arriola-Villalobos P, Luna CMR, Sardiña RC, Delgado-Iribarren A, García-Feijoó J.

Why obesity, hypertension, diabetes, and ethnicities are common risk factors for COVID-19 and H1N1 influenza infections

Miyazawa D.

Consideration on TMPRSS2 and the risk of COVID-19 infection in Cushing's syndrome

Barbot M, Ceccato F, Scaroni C.

Missing during COVID-19 lockdown: children with onset of type 1 diabetes

Dayal D, Gupta S, Raithatha D, Muralidharan J.

Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India

Ghosh A, Arora B, Gupta R, Anoop S, Misra A.

Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies

Mantovani A, Byrne CD, Zheng MH, Targher G.

COVID-19, a viral endocrinological disease?

Grassi T, Varotto E, Galassi FM.

Clinical prediction model for mortality of adult diabetes inpatients with COVID-19 in Wuhan, China: A retrospective pilot study

Su M, Yuan J, Peng J, Wu M, Yang Y, Peng YG.

PERSEVERE OR PERIL: DIABETES CARE IN TIMES OF COVID-19

Barengolts E.

Endourology (Lithiasis). Management, surgical considerations and follow-up of patients in the COVID-19 era

Socarrás MER, Esperto F, Bapstistussi MD, Barufaldi F, Vital MS, Papalia R, Salerno A, Cataldo R, Autrán-Gómez AM, Scarpa RM.

Reflections and recommendations on the COVID-19 pandemic: Should hormone therapy be discontinued?

Cagnacci A, Bonaccorsi G, Gambacciani M; board of the Italian Menopause Society.

Osteoporotic Fractures in the Time of COVID-19

Bhattacharyya T.

Altered Taste in Patients with COVID-19: The Potential Role of Salivary Glands

da Silva Pedrosa M, Sipert CR, Nogueira FN.

The insidious threat of jamu and unregulated traditional medicines in the COVID-19 era

Lim MA, Pranata R.

Letter in response to the article: Vitamin D concentrations and COVID-19 infection in UK biobank (Hastie et al.)

Grant WB, McDonnell SL.

Analyzing barriers for implementation of public health and social measures to prevent the transmission of COVID-19 disease using DEMATEL method

Maqbool A, Khan NZ.

Letter to Editor in response to "COVID-19: From bench to bedside" by Singh et al

Singh A, Shaikh A, Singh R, Singh AK.

Lifestyle changes in patients with morbid obesity and type 2 diabetes mellitus during the COVID-19 pandemic

Wysocki M, Walƒôdziak M, Proczko-Stepaniak M, Pƒôdziwiatr M, Szeliga J, Major P.

Pharmacovigilance in patients with diabetes: A data-driven analysis identifying specific RAS antagonists with adverse pulmonary safety profiles that have implications for COVID-19 morbidity and mortality

Stafford EG, Riviere JE, Xu X, Kawakami J, Wyckoff GJ, Jaberi-Douraki M.

Hypermetabolism and COVID-19

Yu PJ, Cassiere H, DeRosa S, Bocchieri K, Yar S, Hartman A.

Dissecting the Interaction between Coronavirus Disease 2019 and Diabetes Mellitus

Chee YJ, Tan SK, Yeoh E.

Possible role of vitamin D in Covid-19 infection in pediatric population

Panfili FM, Roversi M, D'Argenio P, Rossi P, Cappa M, Fintini D.

Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic-an international perspective

Fleseriu M, Buchfelder M, Cetas JS, Fazeli PK, Mallea-Gil SM, Gurnell M, McCormack A, Pineyro MM, Syro LV, Tritos NA, Marcus HJ.

Greater risk of severe COVID-19 in Black, Asian and Minority Ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25(OH)-vitamin D status: study of 1326 cases from the UK Biobank

Raisi-Estabragh Z, McCracken C, Bethell MS, Cooper J, Cooper C, Caulfield MJ, Munroe PB, Harvey NC, Petersen SE.

Diabetic Ketoacidosis in COVID-19: unique concerns and considerations

Palermo NE, Sadhu AR, McDonnell ME.

Type 2 diabetes as a major risk factor for COVID-19 severity: a meta-analysis

Pinto LC, Bertoluci MC.

Severity of COVID-19 and diabetes mellitus: there is still a lot to be learned

Rodacki M.

Adrenal Insufficiency and Glucocorticoid Use During the COVID-19 Pandemic

Almeida MQ, Mendonca BB.

Endocrinology in the time of COVID-19: Management of neuroendocrine neoplasms (NENs)

Casey RT, Valk GD, Schalin-Jantti C, Grossman AB, Thakker RV.

Update of the hyperglycemia Gestational diagnosis during the COVID-19 pandemic

Codina M, Corcoy R, Goya MM; en representación del GEDE Consenso del Grupo Español de Diabetes y Embarazo (GEDE); GEDE Consenso del Grupo Español de Diabetes y Embarazo (GEDE).

COVID-19 pandemic perception in adults with celiac disease: an impulse to implement the use of telemedicine

Siniscalchi M, Zingone F, Savarino EV, D'Odorico A, Ciacci C.

Delivery of care remotely through telemedicine in celiac disease: Thinking beyond COVID-19: Commentary on: DLD-20-556R1 "COVID-19 pandemic perception in adults with celiac disease: an impulse to implement the use of telemedicine" by Siniscalchi M et al

Ines Pinto-Sanchez M, Lebwohl B.

Is there a link between endocrine disruptors and COVID-19 severe pneumonia?

Ouleghzal H, Rafai M, Elbenaye J.

Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis

Huang Z, Tian D, Liu Y, Lin Z, Lyon CJ, Lai W, Fusco D, Drouin A, Yin X, Hu T, Ning B.

An internet-based algorithm for diabetic foot infection during the COVID-19 pandemic

Liu C, Shi WL, You JX, Li HY, Li L.

COVID -19 outbreak - Diabetes aspect and perspective

Ahirwar AK, Asia P, Sakarde A, Kaim K.

Multi-Organ Failure in a Patient With Diabetes due to COVID-19 With Clear Lungs

Kabashneh S, Ali H, Alkassis S.

COVID-19: The Endocrine opportunity in a pandemic

Chatterjee S, Ghosh R, Biswas P, Dubey S, Guria RT, Sharma CB, Kalra S.

Religion as a Health Promoter During the 2019/2020 COVID Outbreak: View from Detroit

Modell SM, Kardia SLR.

Identifying and managing osteoporosis before and after COVID-19: rise of the remote consultation?

Paskins Z, Crawford-Manning F, Bullock L, Jinks C.

Diabetes and COVID-19: Risks, Management, and Learnings From Other National Disasters

Hartmann-Boyce J, Morris E, Goyder C, Kinton J, Perring J, Nunan D, Mahtani K, Buse JB, Del Prato S, Ji L, Roussel R, Khunti K.

[Impact of the pandemic COVID-19 in andrology. Recommendations in daily clinical practice]

Egui Rojo MA, Fernández-Pascual E, Martínez-Salamanca JI.

Euglycemic diabetic ketoacidosis in a patient with type 1 diabetes and SARS-CoV-2 pneumonia: case report and review of the literature

Oriot P, Hermans MP.

Worldwide ACE (I/D) polymorphism may affect COVID-19 recovery rate: an ecological meta-regression

Hatami N, Ahi S, Sadeghinikoo A, Foroughian M, Javdani F, Kalani N, Fereydoni M, Keshavarz P, Hosseini A.

[Risks factors for death among COVID-19 patients combined with hypertension, coronary heart disease or diabetes]

Yang H, Yang LC, Zhang RT, Ling YP, Ge QG.

Immune monitoring of a child with autoimmune hepatitis and type 1 diabetes during COVID-19 infection

Yuksel M, Akturk H, Arikan C.

Blood Glucose Control During Lockdown for COVID-19: CGM Metrics in Italian Adults With Type 1 Diabetes

Capaldo B, Annuzzi G, Creanza A, Giglio C, De Angelis R, Lupoli R, Masulli M, Riccardi G, Rivellese AA, Bozzetto L.

Diabetes Epidemiology in the COVID-19 Pandemic

Selvin E, Juraschek SP.

Letter to the editor in response to: COVID-19 pandemic and challenges for socio-economic issues, healthcare and national programs in India (Gopalan and Misra)

Pratap Singh R, Kataria R, Ul Haq MF.

Response to the letter of L. Santacroce regarding article "Enhancing immunity in viral infections, with special emphasis on COVID-19: A review" (Jayawardena et al.)

Jayawardena R, Sooriyaarachchi P, Chourdakis M, Jeewandara C, Ranasinghe P.

Redefining diabetic foot disease management service during COVID-19 pandemic

Jaly I, Iyengar K, Bahl S, Hughes T, Vaishya R.

Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane?

Jagat J M, Kalyan K G, Subir R.

Metabolic dysfunction associated fatty liver disease increases risk of severe Covid-19

Sharma P, Kumar A.

COVID-19 and addiction

Dubey MJ, Ghosh R, Chatterjee S, Biswas P, Chatterjee S, Dubey S.

Letter to editor in response to "COVID-19: From bench to bedside" by Singh A et al

Singh H, Prasad Dhibar D.

Metabolic syndrome and COVID-19: An update on the associated comorbidities and proposed therapies

Costa FF, Ros√°rio WR, Ribeiro Farias AC, de Souza RG, Duarte Gondim RS, Barroso WA.

Projections for COVID-19 pandemic in India and effect of temperature and humidity

Goswami K, Bharali S, Hazarika J.

Letter to the Editor: CoVid-19 and Type 1 Diabetes: every cloud has a silver lining. Searching the reason of a lower aggressiveness of the CoronaVirus disease in Type 1 Diabetes

P Tatti, G Tonolo, Zanfardino A, D Iafusco.

Newly diagnosed diabetes and diabetic ketoacidosis precipitated by COVID-19 infection

Heaney AI, Griffin GD, Simon EL.

Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic

Galindo RJ, Aleppo G, Klonoff DC, Spanakis EK, Agarwal S, Vellanki P, Olson DE, Umpierrez GE, Davis GM, Pasquel FJ.

COVID-19 IN DIABETES PATIENTS IN UKRAINE: LESSONS FOR DOCTORS AND PATIENTS

Mankovsky B, Halushko O.

Letter to editor in response to article "COVID-19: From bench to bedside" (Singh et al.)

Singh H, Dhibar DP.

Beyond the virus: Ensuring continuity of care for people with diabetes during COVID-19

Beran D, Aebischer Perone S, Castellsague Perolini M, Chappuis F, Chopard P, Haller DM, Jacquerioz Bausch F, Maisonneuve H, Perone N, Gastaldi G.

Pitfalls in telemedicine consultations in the era of COVID 19 and how to avoid them

Iyengar K, Jain VK, Vaishya R.

Is Metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?

Kumar Singh A, Singh R.

Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A Narrative Review

Kumar Singh A, Khunti K.

COVID19 in South Asians/Asian Indians: Heterogeneity of Data and Implications for Pathophysiology and Research

Gupta R, Misra A.

Tuberculosis and type 2 Diabetes Mellitus: an inflammatory danger signal in the time of COVID-19

Wilkinson RJ.

Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19

Di Filippo L, Formenti AM, Rovere-Querini P, Carlucci M, Conte C, Ciceri F, Zangrillo A, Giustina A.

Positive tracheal SARS-CoV-2 RNA test after three negative SARS-CoV-2 RNA tests in a patient with COVID-19

Vigneshwar NG, Krause M, Bartels K.

Saving the Diabetic Foot During the COVID-19 Pandemic: A Tale of Two Cities

Shin L, Bowling FL, Armstrong DG, Boulton AJM.

Diabetic foot ulceration in COVID-19 lockdown: cause for concern or unexpected benefit?

Lipscomb D, Smith AS, Adamson S, Rezazadeh EM.

Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection

Chew KL, Tan SS, Saw S, Pajarillaga A, Zaine S, Khoo C, Wang W, Tambyah P, Jureen R, Sethi SK.

Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in UK: A retrospective single centre study

Alkundi A, Mahmoud I, Musa A, Naveed S, Alshawaf M.

COVID-19 and Cushing's syndrome: recommendations for a special population with endogenous glucocorticoid excess

Pivonello R, Ferrigno R, Isidori AM, Biller BMK, Grossman AB, Colao A.

New-Onset Diabetes in Covid-19

Rubino F, Amiel SA, Zimmet P, Alberti G, Bornstein S, Eckel RH, Mingrone G, Boehm B, Cooper ME, Chai Z, Del Prato S, Ji L, Hopkins D, Herman WH, Khunti K, Mbanya JC, Renard E.

Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19

Sardu C, Gargiulo G, Esposito G, Paolisso G, Marfella R.

Psychosocial impact of COVID-19

Dubey S, Biswas P, Ghosh R, Chatterjee S, Dubey MJ, Chatterjee S, Lahiri D, Lavie CJ.

Response to 'Vitamin D concentrations and COVID-19 infection in UK Biobank'

Roy AS, Matson M, Herlekar R.

A novel peer-to-peer contact tracking application for COVID-19 and future pandemics

Brown NJ.

Approach to the Patient with Thyrotoxicosis Using Telemedicine

Griffith ML, Bischoff LA, Baum HBA.

Cardiometabolic Risk Factor Control During Times of Crises and Beyond

Brook RD, Levy P, Rajagopalan S.

Worse progression of COVID-19 in men: Is Testosterone a key factor?

Giagulli VA, Guastamacchia E, Magrone T, Jirillo E, Lisco G, De Pergola G, Triggiani V.

Challenges and strategies in management of osteoporosis and fragility fracture care during COVID-19 pandemic

Upadhyaya GK, Iyengar K, Jain VK, Vaishya R.

Recommendations for the care of patients with diabetes mellitus with risk factors or established cardiovascular disease and SARS-CoV-2mellitus con factores de riesgo o enfermedad cardiovascular establecida y SARS-CoV-2

Alcocer-Gamba MA, Gutiérrez-Fajardo P, Sosa-Caballero A, Cabrera-Rayo A, Faradji-Hazan RN, Padilla-Padilla FG, Garnica-Cuellar JC, Hernández-Arispe LM, Reyes-Cianeros FA, León-Suárez A, de-Jesús-Rivera J, Mancillas-Adame L, Gaxiola-Macias M, Márquez-Rodríguez E, Miranda-Malpica E, Sanchez-Pedraza V, Lara-Martínez DS, Segovia-Palomo A, Nava-Hernández A, Rivera-Reyes R.

Coronavirus infection in patients with diabetes

Torres-Tamayo M, Caracas-Portillo NA, Peña-Aparicio B, Juárez-Rojas JG, Medina-Urrutia AX, Martínez-Alvarado MDR.

Corrigendum to Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States

ACCEPTABILITY AND UTILISATION OF NEWER TECHNOLOGIES AND EFFECTS ON GLYCEMIC CONTROL IN TYPE 2 DIABETES - LESSONS LEARNT FROM LOCKDOWN

Anjana RM, Pradeepa R, Deepa M, Jebarani S, Venkatesan U, Parvathi SJ, Balasubramanyam M, Radha V, Poongothai S, Sudha V, Rani CSS, Harish R, Amutha A, Nagaraj M, Ranjit U, Mohan V.

Managing common endocrine disorders amid COVID-19 pandemic

Pal R, Bhadada SK.

Does glycemic control rescue type 2 diabetic patients from COVID-19-related deaths?

Naruse K.

A COVID-19 pneumonia case report of autoimmune polyendocrine syndrome type 1 in Lombardy, Italy: letter to the editor

Beccuti G, Ghizzoni L, Cambria V, Codullo V, Sacchi P, Lovati E, Mongodi S, Iotti GA, Mojoli F.

What Diabetes Can Teach us About Dealing With COVID-19 and Could it Be a Catalyst for Change in Diabetes?

Stuhr A, Furber S.

Post the Pandemic: How will COVID-19 Transform Diabetic Foot Disease Management?

Najafi B.

The Coronavirus 2019 Pandemic and Diabetes: An International Perspective

Klonoff DC.

Glucovigilance in COVID-19

Lamptey R, Ahomagnon S, Acheampong F, Kalra S.

Endocrine vigilance in COVID-19

Velayoudom FL, Alwis Wijewickrama PS, Ranathunga HI, Somasundaram N.

Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view

Berton AM, Prencipe N, Giordano R, Ghigo E, Grottoli S.

Diabetes: Ein Risikofaktor bei COVID-19

Starostzik C.

Endocrine Conditions and COVID-19

Shekhar S, Wurth R, Kamilaris CDC, Eisenhofer G, Barrera FJ, Hajdenberg M, Tonleu J, Hall JE, Schiffrin EL, Porter F, Stratakis CA, Hannah-Shmouni F.

"Does having diabetes increase chances of contracting COVID-19 infection?"

Gangopadhyay KK.

SARS-CoV-2 receptor networks in diabetic kidney disease, BK-Virus nephropathy and COVID-19 associated acute kidney injury

Menon R, Otto EE, Sealfon R, Nair V, Wong AK, Theesfeld CL, Chen X, Wang Y, Boppana A, Kasson PM, Schaub JA, Berthier CC, Eddy S, Lienczewski CC, Godfrey B, Dagenais SL, Sohaney R, Hartman J, Fermin D, Subramanian L, Looker HC, Mariani LH, Naik AS, Nelson RG, Troyanskaya OG, Kretzler M.

Androgen Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men

Ghazizadeh Z, Majd H, Richter M, Samuel R, Zekavat SM, Asgharian H, Farahvashi S, Kalantari A, Ramirez J, Zhao H, Natarajan P, Goodarzi H, Fattahi F.

COVID-19 and diabetes mellitus: implications for prognosis and clinical management

Barber TM.

COVID-19: A Personalized Cardiometabolic Approach for Reducing Complications and Costs. The Role of Aging beyond Topics

Saban-Ruiz J, Ly-Pen D.

Endocrinology in the time of COVID-19: Remodelling Diabetes Services and Promoting Innovation

Wake DJ, Gibb FW, Kar P, Kennon B, Klonoff DC, Rayman G, Rutter MK, Sainsbury C, Semple RK.

Thyroid disease in the time of COVID-19

Dworakowska D, Grossman AB.

Caring for patients with diabetes during COVID-19 pandemic: Important considerations for pharmacists

Elnaem MH, Cheema E.

Telemedicine for Diabetes After the COVID-19 Pandemic: We Can't Put the Toothpaste Back in the Tube or Turn Back the Clock

Klonoff DC.

Why Do People With Diabetes Have a High Risk for Severe COVID-19 Disease?-A Dental Hypothesis and Possible Prevention Strategy

Pfützner A, Lazzara M, Jantz J.

COVID-19: Impact of and on Diabetes

Schofield J, Leelarathna L, Thabit H.

Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19

Solerte SB, Di Sabatino A, Galli M, Fiorina P.

Relationship between COVID-19 and obesity

Ekiz T, Pazarlı AC.

COVID-19 pandemic and challenges for socio-economic issues, healthcare and National Health Programs in India

Gopalan HS, Misra A.

A case of subacute thyroiditis associated with Covid-19 infection

Asfuroglu Kalkan E, Ates I.

Effects of COVID-19 Lockdown on Glucose Control: Continuous Glucose Monitoring Data From People With Diabetes on Intensive Insulin Therapy

Maddaloni E, Coraggio L, Pieralice S, Carlone A, Pozzilli P, Buzzetti R.

Type 1 Diabetes and COVID-19: Preliminary Findings From a Multicenter Surveillance Study in the U.S

Ebekozien OA, Noor N, Gallagher MP, Alonso GT.

Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study

Wu J, Huang J, Zhu G, Wang Q, Lv Q, Huang Y, Yu Y, Si X, Yi H, Wang C, Liu Y, Xiao H, Zhou Q, Liu X, Yang D, Guan X, Li Y, Peng S, Sung J, Xiao H.

Proposed guidelines for screening of hyperglycemia in patients hospitalized with COVID-19 in low resource settings

Goyal A, Gupta S, Gupta Y, Tandon N.

The Australian response to the COVID-19 pandemic and diabetes - lessons learned

Andrikopoulos S, Johnson G.

Recommendations for management of diabetic foot ulcers during COVID-19 outbreak

Kelahmetoglu O, Camlı MF, Kirazoglu A, Erbayat Y, Asgarzade S, Durgun U, Mehdizade T, Yeniocak A, Yildiz K, Sonmez Ergun S, Guneren E.

Endocrine surgery during COVID-19 pandemic: do we need an update of indications in Italy?

Lombardi CP, D'Amore A, Grani G, Ramundo V, Boscherini M, Gordini L, Marzi F, Tedesco S, Bocale R.

An andrologist in the front line Covid-19 team

Baldassarre E.

Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia

Ramírez I, De la Viuda E, Baquedano L, Coronado P, Llaneza P, Mendoza N, Otero B, Sánchez S, Cancelo MJ, Páramo JA, Cano A.

A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic

Korytkowski M, Antinori-Lent K, Drincic A, Hirsch IB, McDonnell ME, Rushakoff R, Muniyappa R.

COVID-19 and applications of smartphone technology in the current pandemic

Iyengar K, Upadhyaya GK, Vaishya R, Jain V.

Management of diabetic persons with foot ulceration during COVID-19 health care emergency: effectiveness of a new triage pathway

Marco M, Valentina I, Laura G, Roberto G, Luigi U.

Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 infection

Wu J, Zhang J, Sun X, Wang L, Xu Y, Zhang Y, Liu X, Dong C.

Standardized out-patient diagnosis and treatment process for osteoporosis clinics during the COVID-19 pandemic

Zou J, Song DW, Niu JJ, Shi JW, Yang HL.

Gender differences in COVID-19 infection. The estrogen effect on upper and lower airways. Can it help to figure out a treatment?

Di Stadio A, Della Volpe A, Ralli M, Ricci G.

COVID-19: is there a link between the course of infection and pharmacological agents in diabetes?

Filardi T, Morano S.

A New Drug-Drug Interaction Between Hydroxychloroquine and Metformin? A Signal Detection Study

Montastruc JL, Toutain PL.

Covid-19: Pandemic is having "severe" impact on non-communicable disease care, WHO survey finds

Dyer O.

Diabetes and covid-19: more than the sum of two morbidities

Pititto BA, Ferreira SRG.

Serious Conditions in COVID-19 Accompanied With a Feature of Metabolic Syndrome

Nakajima K.

Managing Type 2 Diabetes Mellitus during COVID-19 Pandemic: The Bittersweet

Yehya A, Carbone S.

Possible long-term endocrine-metabolic complications in COVID-19: lesson from the SARS model

Mongioì LM, Barbagallo F, Condorelli RA, Cannarella R, Aversa A, La Vignera S, Calogero AE.

SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report

Ippolito S, Dentali F, Tanda ML.

Endocrine complications of COVID-19: what happens to the thyroid and adrenal glands?

Bellastella G, Maiorino MI, Esposito K.

Partha Kar: Covid-19-time for parity in commissioning diabetes services

Kar P.

COVID-19 Awakens a New Focus on Surge Capacity Blood Glucose Testing and the Critical Role of Telehealth in Self-Management

Fantz CR, Rivers M.

Inpatient Diabetes Management During the COVID-19 Crisis: Experiences From Two Community Hospitals

Shelton C, Demidowich AP, Zilbermint M.

COVID-19: The Underestimated Pandemic Impacting People With Diabetes

Shearer D.

New Paradigms in Diabetes Management From the Epicenter

Levy CJ, Levister CM, Shah NA.

Sodium-Glucose Cotransporter 2 Inhibitors in the Era of COVID-19 Pandemic: Is the Benefit to Risk Ratio Still Favorable?

Koufakis T, Metallidis S, Zebekakis P, Ajjan RA, Kotsa K.

Covid-19 and Diabetes in Hawaii

Melish JS.

Battlefield Endocrinology

Sadhu AR.

Diabetes and severity of COVID-19: What is the link?

Pitocco D, Viti L, Tartaglione L, Di Leo M, Rizzo GE, Manto A, Rizzi A, Caputo S, Pontecorvi A.

Neck circumference as reliable predictor of mechanical ventilation support in adult inpatients with COVID-19: a multicentric prospective evaluation

Di Bella S, Cesareo R, De Cristofaro P, Palermo A, Sanson G, Roman-Pognuz E, Zerbato V, Manfrini S, Giacomazzi D, Dal Bo E, Sambataro G, Macchini E, Quintavalle F, Campagna G, Masala R, Ottaviani L, Del Borgo C, Ridola L, Leonetti F, Berlot G, Luzzati R.

COVID-19: Perspectives from people with diabetes

COVID-19 Pandemic Triggers Telemedicine Regulation and Intensifies Diabetes Management Technology Adoption in Brazil

Teles M, Sacchetta T, Matsumoto Y.

Responding to COVID-19: Agile Use of Information Technology to Serve Patients With Diabetes

Waki K, Sankoda A, Amano S, Ogawa M, Ohe K.

Breastfeeding during the COVID-19 pandemic: suggestions on behalf of Woman Study Group of AMD

Giuliani C, Li Volsi P, Brun E, Chiambretti A, Giandalia A, Tonutti L, Di Bartolo P, Napoli A.

Related molecular mechanisms of COVID-19, hypertension, and diabetes

Akkus E, Sahin M.

A Case of COVID-19 Patient with False-negative for SARS-CoV-2 of Pharyngeal Swab, from a Chinese traveller Returning from Wuhan, Hubei Province, China, January 2020

Ishikane M, Miyazato Y, Kustuna S, Suzuki T, Ide S, Nakamura K, Morioka S, Katano H, Suzuki T, Ohmagari N.

Consequences of COVID-19 on people with diabetes

Bellido V, Pérez A.

COVID-19 and Diabetes: Could Diabetes Technology Research Help Pave the Way for Remote Healthcare?

Fuchs J, Hovorka R.

COVID-19: Considerations of Diabetes and Cardiovascular Disease Management

Ceriello A, Schnell O.

Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico

Bello-Chavolla OY, Bahena-López JP, Antonio-Villa NE, Vargas-Vázquez A, González-Díaz A, Márquez-Salinas A, Fermín-Martínez CA, Naveja JJ, Aguilar-Salinas CA.

Monitoring COVID-19 through Trends in Influenza-like Illness and Laboratory-confirmed Influenza and COVID-19 - New York State, excluding New York City, January 1 - April 12, 2020

Rosenberg ES, Hall EW, Rosenthal EM, Maxted AM, Gowie DL, Dufort EM, Blog DS, Hoefer D, St George K, Hutton BJ, Zucker HA; New York State Coronavirus 2019 Response Team.

Challenges of diabetes care management in developing countries with a high incidence of COVID-19: A brief report

Nouhjah S, Jahanfar S.

Reply to the letter of Mahajan and Gaur in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.)

Singh AK, Gupta R, Misra A.

Does poor glucose control increase the severity and mortality in patients with diabetes and COVID-19?

Singh AK, Singh R.

Letter in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.)

Mahajan K, Gaur N.

COVID-19 and diabetes: Is there enough evidence?

Tadic M, Cuspidi C, Sala C.

Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study

Cariou B, Hadjadj S, Wargny M, Pichelin M, Al-Salameh A, Allix I, Amadou C, Arnault G, Baudoux F, Bauduceau B, Borot S, Bourgeon-Ghittori M, Bourron O, Boutoille D, Cazenave-Roblot F, Chaumeil C, Cosson E, Coudol S, Darmon P, Disse E, Ducet-Boiffard A, Gaborit B, Joubert M, Kerlan V, Laviolle B, Marchand L, Meyer L, Potier L, Prevost G, Riveline JP, Robert R, Saulnier PJ, Sultan A, Thébaut JF, Thivolet C, Tramunt B, Vatier C, Roussel R, Gautier JF, Gourdy P; CORONADO investigators.

Diabetes and COVID-19

Bouhanick B, Cracowski JL, Faillie JL; French Society of Pharmacology, Therapeutics (SFPT).

The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike

Li Y, Zhang Z, Yang L, Lian X, Xie Y, Li S, Xin S, Cao P, Lu J.

Role of oxidized LDL-induced "trained macrophages" in the pathogenesis of COVID-19 and benefits of pioglitazone: A hypothesis

Erol A.

Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19

Li H, Tian S, Chen T, Cui Z, Shi N, Zhong X, Qiu K, Zhang J, Zeng T, Chen L, Zheng J.

The gendered impact of coronavirus disease (COVID-19): do estrogens play a role?

Grandi G, Facchinetti F, Bitzer J.

COVID-19, Type 1 Diabetes Clinical Practice, Research, and Remote Medical Care: A View From the Land Down-Under

Venkatesh N, Paldus B, Lee MH, MacIsaac RJ, Jenkins AJ, O'Neal DN.

Diabetes Care at the Times of Transition and COVID-19 Pandemics (Ukrainian Experience)

Mankovsky B.

Challenges in the Care of Children and Youth With Diabetes in Times of the Corona Pandemic: Personal View of the Situation in a German Clinic

Ziegler R.

Relative Limited Impact of COVID-19 on Diabetes: A Personal View

de Galan BE.

COVID-19 may affect the endocrine pancreas by activating Na(+)/H(+) exchanger 2 and increasing lactate levels

Cure E, Cumhur Cure M.

GP at foot: remote ways to share management of diabetes amid the COVID-19 crisis

Chambers R, Beaney P, Balasubramanian G, Ogunmekan S.

Metabolic Impacts of Confinement during the COVID-19 Pandemic Due to Modified Diet and Physical Activity Habits

Martinez-Ferran M, de la Guía-Galipienso F, Sanchis-Gomar F, Pareja-Galeano H.

Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19

Menendez JA.

Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study

Fadini GP, Morieri ML, Longato E, Bonora BM, Pinelli S, Selmin E, Voltan G, Falaguasta D, Tresso S, Costantini G, Sparacino G, Di Camillo B, Tramontan L, Cattelan AM, Vianello A, Fioretto P, Vettor R, Avogaro A.

Why is hyperglycemia worsening COVID-19 and its prognosis?

Ceriello A, De Nigris V, Prattichizzo F.

SARS-CoV-2 infection, male fertility and sperm cryopreservation: a position statement of the Italian Society of Andrology and Sexual Medicine (SIAMS) (Società Italiana di Andrologia e Medicina della Sessualità)

Corona G, Baldi E, Isidori AM, Paoli D, Pallotti F, De Santis L, Francavilla F, La Vignera S, Selice R, Caponecchia L, Pivonello R, Ferlin A, Foresta C, Jannini EA, Lenzi A, Maggi M, Lombardo F.

Would You Believe? A Virus Changes Diabetes Care

Tack CCJ.

The COVID-19 Pandemic Revealed the Importance and Shortcomings of Technologies for Diabetes Support

√Örsand E.

Diabetes and Technology in the Covid-19 Pandemic Crisis

Spanakis EK.

Personal Experiences With COVID-19 and Diabetes Technology: All for Technology Yet Not Technology for All

Monaghan M, Marks B.

Personal Experience With COVID-19 and Community Screening of Diabetic Retinopathy in Iran

Jamali S, Ashrafi E, Mohammadi SF.

Benefits of Technology in the Age of COVID-19 and Diabetes. . .Mobile Phones From a Rwanda Perspective

Krisiunas E, Sibomana L.

Comment on "Is the type of diabetes treatment relevant to outcome of COVID-19?"

Pal R, Banerjee M.

COVID-19 and diabetes: The why, the what and the how

Cuschieri S, Grech S.

Some Lessons Learned About Diabetes and COVID-19 During the Early Stage of the Epidemic in Norway

Birkeland KI.

Potential Benefits and Harms of Novel Antidiabetic Drugs During COVID-19 Crisis

Mirabelli M, Chiefari E, Puccio L, Foti DP, Brunetti A.

Smoking-Mediated Upregulation of the Androgen Pathway Leads to Increased SARS-CoV-2 Susceptibility

Chakladar J, Shende N, Li WT, Rajasekaran M, Chang EY, Ongkeko WM.

Endocrinology in the time of COVID-19: Diagnosis and Management of Gestational Diabetes Mellitus

Thangaratinam S, Cooray SD, Sukumar N, Huda MS, Devlieger R, Benhalima K, McAuliffe F, Saravanan P, Teede H.

A new diagnostic strategy for gestational diabetes during the COVID-19 pandemic for the Japanese population

Kasuga Y, Saisho Y, Ikenoue S, Ochiai D, Tanaka M.

In response: Diabetes is a risk factor for the progression and prognosis of COVID-19

Blanke CD.

Understanding immune effects of oestrogens to explain the reduced morbidity and mortality in female versus male COVID-19 patients. Comparisons with autoimmunity and vaccination

Cutolo M, Smith V, Paolino S.

Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: may all fit together?

Berni A, Malandrino D, Parenti G, Maggi M, Poggesi L, Peri A.

The contribution of diabetic micro-angiopathy to adverse outcomes in COVID-19

Whyte MB, Vas P, Heiss C, Feher MD.

The COVID-19 Pandemic: A "Tech"-tonic Shift Toward Virtual Diabetes Care

Ahn DT.

Letter to the Editor: Our Response to Covid-19 as Endocrinologists and Diabetologists

Snyder S.

Endocrine surgery during and after the COVID-19 epidemic: Expert guidelines from AFCE

Baud G, Brunaud L, Lifante JC, Tresallet C, Sebag F, Bizard JP, Mathonnet M, Menegaux F, Caiazzo R, Mirallié E, Pattou F; AFCE COVID Study Group.

Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients

Marfella R, Paolisso P, Sardu C, Bergamaschi L, D'Angelo EC, Barbieri M, Rizzo MR, Messina V, Maggi P, Coppola N, Pizzi C, Biffi M, Viale P, Galié N, Paolisso G.

Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports

Scheen AJ, Marre M, Thivolet C.

COVID-19 symptoms masking inaugural ketoacidosis of type 1 diabetes

Potier L, Julla JB, Roussel R, Boudou P, Gauthier DC, Ketfi C, Gautier JF.

Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients - the "Gabrin sign"

Wambier CG, Vaño-Galván S, McCoy J, Gomez-Zubiaur A, Herrera S, Hermosa-Gelbard Á, Moreno-Arrones OM, Jiménez-Gómez N, González-Cantero A, Pascual PF, Segurado-Miravalles G, Shapiro J, Pérez-García B, Goren A.

SARS-CoV-2 and Diabetes: New Challenges for the Disease

Cristelo C, Azevedo C, Moreira Marques J, Nunes R, Sarmento B.

Characteristics and Outcomes of COVID-19 Positive Patients with Diabetes Managed as Outpatients

Shabto JM, Loerinc L, O'Keefe GA, O'Keefe J.

Metformin, Neutrophils and COVID-19 Infection

Dalan R.

Association of Diabetes Mellitus with Disease Severity and Prognosis in COVID-19: A Retrospective Cohort Study

Zhang Y, Cui Y, Shen M, Zhang J, Liu B, Dai M, Chen L, Han D, Fan Y, Zeng Y, Li W, Lin F, Li S, Chen X, Pan P; medical team from Xiangya Hospital to support Hubei, China.

Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis

Luo P, Qiu L, Liu Y, Liu XL, Zheng JL, Xue HY, Liu WH, Liu D, Li J.

Early Observation and Mitigation of Challenges in Diabetes Management of COVID-19 Patients in Critical Care Units

Hamdy O, Gabbay RA.

How COVID-19 Rapidly Transformed Clinical Practice at the Harold Schnitzer Diabetes Health Center Now and for the Future

Castle JR, Rocha L, Ahmann A.

Glucose Monitoring and Diabetes Management in the Time of Coronavirus Disease 2019

Welsh JB, Hu G, Walker TC, Sharma N, Cherñavvsky D.

Time for a Change: Personal Experiences With COVID-19 and Diabetes

Best F.

Personal Experiences With Coronavirus Disease 2019 and Diabetes: The Time for Telemedicine is Now

Mader JK.

TYPE 1 DIABETES TRIGGERED BY COVID-19 PANDEMIC: A POTENTIAL OUTBREAK?

Caruso P, Longo M, Esposito K, Ida Maiorino M.

Type 1 diabetes and technology at time of COVID -19. A case report

Cordera R, Pinducciu C, Maggi D.

Management of Graves' hyperthyroidism and orbitopathy in time of COVID-19 pandemic

Bartalena L, Chiovato L, Marcocci C, Vitti P, Piantanida E, Tanda ML.

Supporting People With Diabetes, Through COVID-19 and Beyond

Boulton C.

Teleconsultation and Diabetes Care Amid COVID-19 Pandemic in India: Scopes and Challenges

Banerjee M, Chakraborty S, Pal R.

The COVID-19 Pandemic during the Time of the Diabetes Pandemic: Likely Fraternal Twins?

Cole SA, Laviada-Molina HA, Serres-Perales JM, Rodriguez-Ayala E, Bastarrachea RA.

Endocrinology in the time of COVID-19: Management of thyroid nodules and cancer

Vrachimis A, Iacovou I, Giannoula E, Giovanella L.

Endocrinology in the time of COVID-19: Management of hyper- and hypo- thyroidism

Boelaert K, Visser WE, Taylor PN, Moran C, Leger J, Persani L.

COVID-19 and diabetes mellitus: A need for prudence in elderly patients from a pooled analysis

Desai R, Singh S, Parekh T, Sachdeva S, Sachdeva R, Kumar G.

Diabetes and metabolic syndrome as risk factors for COVID-19

Marhl M, Grubelnik V, Magdič M, Markovič R.

Convalescent plasma: A possible treatment protocol for COVID- 19 patients suffering from diabetes or underlying liver diseases

Pawar AY, Hiray AP, Sonawane DD, Bhambar RS, Derle DV, Ahire YS.

Significant applications of virtual reality for COVID-19 pandemic

Singh RP, Javaid M, Kataria R, Tyagi M, Haleem A, Suman R.

Obesity as a predictor for a poor prognosis of COVID-19: A systematic review

Tamara A, Tahapary DL.

Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines

Jozaghi Y, Zafereo ME, Perrier ND, Wang JR, Grubbs E, Gross ND, Fisher S, Sturgis EM, Goepfert RP, Lai SY, Best C, Busaidy NL, Cabanillas ME, Dadu R, Gagel RF, Habra MA, Hu MI, Jimenez C, Sherman SI, Thosani S, Varghese J, Waguespack SG, Weitzman S, Ying AK, Graham PH.

Subacute thyroiditis after SARS-CoV-2 infection

Brancatella A, Ricci D, Viola N, Sgrò D, Santini F, Latrofa F.

Metabolic associated fatty liver disease increases COVID-19 disease severity in non-diabetic patients

Gao F, Zheng KI, Wang XB, Yan HD, Sun QF, Pan KH, Wang TY, Chen YP, George J, Zheng MH.

Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients

Rastrelli G, Di Stasi V, Inglese F, Beccaria M, Garuti M, Di Costanzo D, Spreafico F, Greco GF, Cervi G, Pecoriello A, Magini A, Todisco T, Cipriani S, Maseroli E, Corona G, Salonia A, Lenzi A, Maggi M, De Donno G, Vignozzi L.

Diabetes and COVID-19 : Disease-Management-People

Peric S, Stulnig TM.

Diabetic Kidney Disease and COVID-19: The Crash of Two Pandemics

D'Marco L, Puchades MJ, Romero-Parra M, Gorriz JL.

Judicious Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes on Coronavirus-19 Pandemic

Chen CF, Chen YT, Chen TH, Chen FY, Yang YP, Wang ML, Huo TI, Chang YL, Tan AC, Lin CC.

North American Neuroendocrine Tumor Society Guide for Neuroendocrine Tumor Patient Health Care Providers During COVID-19

Bergsland EK, Halperin DM, Dillon JS, Dasari NA, Kunz PL, Soares HP, Pryma D, Bodei L, Hope T, Soulen MC, Mailman J, Howe JR.

Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits

Rao S, Lau A, So HC.

Outcomes in Patients With Hyperglycemia Affected by Covid-19: Can We Do More on Glycemic Control?

Sardu C, D'Onofrio N, Balestrieri ML, Barbieri M, Rizzo MR, Messina V, Maggi P, Coppola N, Paolisso G, Marfella R.

Telemedicine Consultations and Diabetes Technology During COVID-19

N√∏rgaard K.

Personal Experience With COVID-19 and Diabetes in the South of France: Technology Facilitates the Management of Diabetes in Disruptive Times

Renard E.

Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies

Singh AK, Singh A, Singh R, Misra A.

Angiotensin converting enzyme-2 as therapeutic target in COVID-19

Roshanravan N, Ghaffari S, Hedayati M.

The diabetic lung: an easy target for SARS-CoV-2?

Caruso I, Giorgino F.

Diabetes mellitus: Lessons from the COVID-19 pandemic

Tousoulis D.

COVID-19 and diabetes: No time to drag our feet during an untimely pandemic

Kyrou I, Robbins T, Randeva HS.

Systemic endothelial dysfunction: a common pathway for COVID-19, cardiovascular and metabolic diseases

De Lorenzo A, Escobar S, Tibiriçá E.

Diabetes and COVID-19

Bouhanick B, Cracowski JL, Faillie JL; French Society of Pharmacology and Therapeutics (SFPT).

[SOLVING ONE OF THE PIECES OF THE PUZZLE: COVID-19 AND TYPE 2 DIABETES]

Pérez-Martínez P, Carrasco Sánchez FJ, Carretero Gómez J, Gómez-Huelgas R.

How diabetes management is adapting amid the COVID-19 pandemic

Ranscombe P.

Guidance on the management of Diabetic Ketoacidosis in the exceptional circumstances of the COVID-19 pandemic.

Rayman G, Lumb A, Kennon B, Cottrell C, Nagi D, Page E, Voigt D, Courtney H, Atkins H, Platts J, Higgins K, Dhatariya K, Patel M, Narendran P, Kar P, Newland-Jones P, Stewart R, Burr O, Thomas S.

Glycemic control in type 1 diabetes mellitus during COVID-19 quarantine and the role of in-home physical activity.

Tornese G, Ceconi V, Monasta L, Carletti C, Faleschini E, Barbi E.

Surgical treatment of diabetic foot ulcers during the COVID-19 pandemic in China

Tao F, Tang X, Tao H, Luo Y, Cao H, Xiang W, Zhao Y, Jin L.

Diabetes during the COVID-19 Pandemic: A Global Call to Reconnect with Patients and Emphasize Lifestyle Changes and Optimise Glycemic and Blood Pressure Control.

Misra A, Bloomgarden Z.

COVID-19 and Gynecomastia: What is the Relationship?

Kazemi MA, Hemmati S, Moradi B, Sharifian H, Firooznia K, Nikravangolsefid N.

New Guidance on Managing Inpatient Hyperglycaemia during the COVID-19 Pandemic.

Rayman G, Lumb A, Kennon B, Cottrell C, Nagi D, Page E, Voigt D, Courtney H, Atkins H, Platts J, Higgins K, Dhatariya K, Patel M, Narendran P, Kar P, Newland-Jones P, Stewart R, Burr O, Thomas S.

Mechanism of inflammatory response in associated comorbidities in COVID-19

de Lucena TMC, da Silva Santos AF, de Lima BR, de Albuquerque Borborema ME, de Azevêdo Silva J.

"Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis."

Singh AK, Singh A, Singh R, Misra A.

Coping with diabetes during the COVID - 19 lockdown in India: Results of an online pilot survey

Nachimuthu S, Vijayalakshmi R, Sudha M, Viswanathan V.

Roadblock in application of telemedicine for diabetes management in India during COVID19 pandemic

Ghosh A, Dutta K, Tyagi K, Gupta R, Misra A.

Is it fair to hope that patients with Type 1 Diabetes (autoimmune) may be spared by the infection of Covid-19?

Tatti P, Tonolo G, Zanfardino A, Iafusco D.

Patients with diabetes are at higher risk for severe illness from COVID-19

Targher G, Mantovani A, Wang XB, Yan HD, Sun QF, Pan KH, Byrne CD, Zheng KI, Chen YP, Eslam M, George J, Zheng MH.

Nexus of COVID-19 and diabetes pandemics: global public health lessons

Bergman M, Jagannathan R, Venkat Narayan KM.

Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients

Wang Z, Du Z, Zhu F.

Is DPP4 inhibition a comrade or adversary in COVID-19 Infection

Dalan R.

Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores.

Targher G, Mantovani A, Byrne CD, Wang XB, Yan HD, Sun QF, Pan KH, Zheng KI, Chen YP, Eslam M, George J, Zheng MH.

The challenges and benefits of online teaching about diabetes during the COVID-19 pandemic.

Social isolation during Covid-19: Boon or bane to diabetes management.

COVID-19 in diabetic patients: related risks and specifics of management.

Hirsutism, Amphetamines, COVID-19 Viral Shedding, Hand-Foot-and-Mouth Disease.

[No authors listed]

Androgen sensitivity gateway to COVID-19 disease severity.

Wambier CG, Goren A, Vaño-Galván S, Ramos PM, Ossimetha A, Nau G, Herrera S, McCoy J.

Geographic access to United States SARS-CoV-2 testing sites highlights healthcare disparities and may bias transmission estimates.

Rader B, Astley CM, Sy KTL, Sewalk K, Hswen Y, Brownstein JS, Kraemer MUG.

Antibody Testing For Covid-19.

Mathur G, Mathur S.

Diabetes and COVID-19: evidence, current status and unanswered research questions.

Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature.

Katulanda P, Dissanayake HA, Ranathunga I, Ratnasamy V, Wijewickrama PSA, Yogendranathan N, Gamage KKK, de Silva NL, Sumanatilleke M, Somasundaram NP, Matthews DR.

Ensuring continuity of care for children with inherited metabolic diseases at the time of COVID-19: the experience of a metabolic unit in Italy.

Brunetti-Pierri N, Fecarotta S, Staiano A, Strisciuglio P, Parenti G.

COVID-19 in People With Diabetes: Urgently Needed Lessons From Early Reports.

Riddle MC, Buse JB, Franks PW, Knowler WC, Ratner RE, Selvin E, Wexler DJ, Kahn SE.

Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.

Shi Q, Zhang X, Jiang F, Zhang X, Hu N, Bimu C, Feng J, Yan S, Guan Y, Xu D, He G, Chen C, Xiong X, Liu L, Li H, Tao J, Peng Z, Wang W.

The Diagnosis and Management of Gestational Diabetes Mellitus in the Context of the COVID-19 Pandemic.

McIntyre HD, Moses RG.

Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era.

Ceriello A, Standl E, Catrinoiu D, Itzhak B, Lalic NM, Rahelic D, Schnell O, Škrha J, Valensi P; Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group..

Remote Glucose Monitoring of Hospitalized, Quarantined Patients With Diabetes and COVID-19.

Shehav-Zaltzman G, Segal G, Konvalina N, Tirosh A.

Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.

Chen Y, Yang D, Cheng B, Chen J, Peng A, Yang C, Liu C, Xiong M, Deng A, Zhang Y, Zheng L, Huang K.

Opportunities for Research for COVID-19 in the Mission of NIDDK.

Cefalu WT, James SP, Star RA.

Understanding novel COVID-19: Its impact on organ failure and risk assessment for diabetic and cancer patients.

International Diabetes Center: COVID-19 Won't Stop Us From Fulfilling Our Mission.

Davidson JL, Johnson ML, Simonson GD, Criego AB, Martens TW, Carlson AL, Bergenstal RM.

Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis.

Age but not sex may explain the negative effect of arterial hypertension and diabetes on COVID-19 prognosis.

Prevalence of diabetes mellitus in 2019 novel coronavirus: a Meta-analysis.

Supporting people with diabetes during a pandemic.

Skinner T, Speight J.

The Clinical Characteristics and Outcomes of Diabetes Mellitus and Secondary Hyperglycaemia Patients with Coronavirus Disease 2019: a Single-center, Retrospective, Observational Study in Wuhan.

Zhang Y, Li H, Zhang J, Cao Y, Zhao X, Yu N, Gao Y, Ma J, Zhang H, Zhang J, Guo X, Liu X.

Osteoporosis Management in the Era of COVID-19.

Yu EW, Tsourdi E, Clarke BL, Bauer DC, Drake MT.

Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature.

Katulanda P, Dissanayake HA, Ranathunga I, Ratnasamy V, Wijewickrama PSA, Yogendranathan N, Gamage KKK, de Silva NL, Sumanatilleke M, Somasundaram NP, Matthews DR.

The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike.

Li Y, Zhang Z, Yang L, Lian X, Xie Y, Li S, Xin S, Cao P, Lu J.

Starting ADHD medications during the COVID-19 pandemic: recommendations from the European ADHD Guidelines Group.

Cortese S, Coghill D, Santosh P, Hollis C, Simonoff E; European ADHD Guidelines Group..

The Impact of COVID-19 on Diabetes Research in Canada.

Dyck JRB.

COVID-19: A Personalized Cardiometabolic Approach for Reducing Complications and Costs. The Role of Aging Beyond Topics.

Saban-Ruiz J, Ly-Pen D.

The contribution of diabetic micro-angiopathy to adverse outcomes in COVID-19.

Whyte MB, Vas P, Heiss C, Feher MD.

Diabetes and COVID-19: evidence, current status and unanswered research questions.

Gupta R, Hussain A, Misra A.

Letter to the editors in response to: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic (Cure et al.).

Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: risks and benefits at the time of COVID-19 pandemic.

Infante M, Ricordi C, Fabbri A.

Evaluating the efficiency of specimen pooling for PCR-based detection of COVID-19.

Wacharapluesadee S, Kaewpom T, Ampoot W, Ghai S, Khamhang W, Worachotsueptrakun K, Wanthong P, Nopvichai C, Supharatpariyakorn T, Putcharoen O, Paitoonpong L, Suwanpimolkul G, Jantarabenjakul W, Hemachudha P, Krichphiphat A, Buathong R, Plipat T, Hemachudha T.

Ethical framework for head and neck endocrine surgery in the COVID-19 pandemic.

Chen AY, Shindo M.

COVID-19 and Diabetes-A View From India.

Mohan V.

Covid-19 associated SIADH; a clue in the times of pandemic!

Yousaf Z, Al-Shokri SD, Al-Soub H, Mohamed MFH.

No deleterious effect of lockdown due to COVID-19 pandemic on glycaemic control, measured by glucose monitoring, in adults with type 1 diabetes.

Beato-Víbora PI.

Managing Diabetes in Pregnancy before, during and after COVID-19.

Murphy H.

Endocrinology in the time of COVID-19: Management of calcium disorders and osteoporosis.

Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy.

Impact of sedentarism due to the COVID-19 home confinement on neuromuscular, cardiovascular and metabolic health: Physiological and pathophysiological implications and recommendations for physical and nutritional countermeasures.

Narici M, De Vito G, Franchi M, Paoli A, Moro T, Marcolin G, Grassi B, Baldassarre G, Zuccarelli L, Biolo G, di Girolamo FG, Fiotti N, Dela F, Greenhaff P, Maganaris C.

Covid-19 and co-morbidities: a role for Dipeptidyl Peptidase 4 (DPP4) in disease severity?

Bassendine MF, Bridge SH, McCaughan GW, Gorrell MD.

Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy.

Bonora BM, Boscari F, Avogaro A, Bruttomesso D, Fadini GP.

Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19.

Ren H, Yang Y, Wang F, Yan Y, Shi X, Dong K, Yu X, Zhang S.

The challenges of COVID-19 for people living with diabetes: considerations for digital health.

Gamble A, Pham Q, Goyal S, Cafazzo JA.

Role of Non-Profit Organization During COVID-19 for Diabetes Care: Healthcare Inequities and Role of Virtual Specialty Clinic.

Panzirer D.

Diabetes and COVID-19: psychosocial consequences of the COVID-19 pandemic in people with diabetes in Denmark-what characterizes people with high levels of COVID-19-related worries?

Joensen LE, Madsen KP, Holm L, Nielsen KA, Rod MH, Petersen AA, Rod NH, Willaing I.

Epidemics will always come (and go): the need to prepare for the next one, research on COVID-19, and the role of molecular and cellular endocrinology.

Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States.

Bode B, Garrett V, Messler J, McFarland R, Crowe J, Booth R, Klonoff DC.

Do novel drugs for diabetes will help in COVID-19? Another brick in the wall?

Krejner-Bienias A, Grzela K, Grzela T.

Reply to Rheumatologists' perspective on coronavirus disease 19: is heparin the dark horse for COVID-19?

Ahmed S, Anirvan P.

The COVID-19 pandemic: the use of telemedicine in elderly patients with type 2 diabetes.

Fatyga E, Dzięgielewska-Gęsiak S, Wierzgoń A, Stołtny D, Muc-Wierzgoń M.

The Italian Endo-COVID-19. Our response to the emergency.

Isidori AM, Jannini EA, Lenzi A, Ghigo E; Board of Full Professors in Endocrinology, Directors of the Endocrinology, Metabolic Disorders Residency Program..

Home-based training strategy to maintain muscle function in older adults with diabetes during COVID-19 confinement.

Guadalupe-Grau A, López-Torres O, Martos-Bermúdez Á, González-Gross M.

Diabetes or endocrinopathy admitted in the Covid19 ward.

Clotman K, Twickler TB.

COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher's Stone?

Penlioglou T, Papachristou S, Papanas N.

Letter to the Editor: "Our Response to COVID-19 as Endocrinologists and Diabetologists".

Dhaliwal R, Bhadada SK, Rao SD.

COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher's Stone?

Penlioglou T, Papachristou S, Papanas N.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis.

Steenblock C, Todorov V, Kanczkowski W, Eisenhofer G, Schedl A, Wong ML, Licinio J, Bauer M, Young AH, Gainetdinov RR, Bornstein SR.

Chloroquine and the potential adverse outcome in undiagnosed G6PD-deficient cases infected with COVID-19.

Khneisser I, Farra C.

Diabetes and COVID-19-the meeting of two pandemics: what are the concerns?

Coppell KJ, Hall RM, Downie M, Fraser SK, Garrett M, Jefferies CA, Kenealy TW, Milne RE, Orr-Walker BJ, Paul RG, Smallman K, Snell HJ.

The Use of eHealth for the Care of Patients With Diabetes in Connection to the COVID-19 Pandemic.

Jendle J.

[Diabetes and COVID-19 infection].

Kosinski C, Zanchi A, Wojtusciszyn A.

Hyperglycemia management in the critically ill patient with COVID-19.

Al-Jaghbeer MJ, Lansang MC.

Individualizing Inpatient Diabetes Management During the Coronavirus Disease 2019 Pandemic.

Pasquel FJ, Umpierrez GE.

A Neuroendocrine Tumor Specialty Center in New Orleans (NOLANETS) Response to Patient Care During the COVID-19 Pandemic.

Ramirez RA, Bren-Mattison Y, Thiagarajan R, Boudreaux JP, Marsala AJ, Ryan P, Maluccio MA.

Guidelines for the management of diabetes in care homes during the Covid-19 pandemic.

Sinclair A, Dhatariya K, Burr O, Nagi D, Higgins K, Hopkins D, Patel M, Kar P, Gooday C, Howarth D, Abdelhafiz A, Newland-Jones P, O'Neill S.

Guidelines for the management of diabetes services and patients during the COVID-19 pandemic.

Rayman G, Lumb A, Kennon B, Cottrell C, Nagi D, Page E, Voigt D, Courtney H, Atkins H, Platts J, Higgins K, Dhatariya K, Patel M, Narendran P, Kar P, Newland-Jones P, Stewart R, Burr O, Thomas S; London Inpatient Diabetes Network-COVID-19..

COVID-19 and the endocrine system: exploring the unexplored.

Pal R, Banerjee M.

CLINICAL CHARACTERISTICS OF 28 PATIENTS WITH DIABETES AND COVID-19 IN WUHAN, CHINA.

Wang F, Yang Y, Dong K, Yan Y, Zhang S, Ren H, Yu X, Shi X.

[Endocrine surgery during and after the COVID-19 epidemic: guidelines from AFCE].

Baud G, Brunaud L, Lifante JC, Tresallet C, Sebag F, Bizard JP, Mathonnet M, Menegaux F, Caiazzo R, Mirallié É, Pattou F.

Is the type of diabetes treatment relevant to outcome of COVID-19?

Bloomgarden Z.

The Need for Diabetes Care Customization in the ICU at the Time of SARS-CoV-2 Outbreak.

Gentile S, Strollo F, Ceriello A.

The Need for Diabetes Care Customization in the ICU at the Time of SARS-CoV-2 Outbreak.

Gentile S, Strollo F, Ceriello A.

Metformin and COVID-19: A novel deal of an Old Drug.

El-Arabey AA, Abdalla M.

Summary of recommendations regarding COVID-19 in children with diabetes: Keep Calm and Mind your Diabetes Care and Public Health Advice.

International Society of Pediatric and Adolescent Diabetes (ISPAD)..

Severe hypocalcemia in a thyroidectomized woman with Covid-19 infection.

Bossoni S, Chiesa L, Giustina A.

COVID-19, hypothalamo-pituitary-adrenal axis and clinical implications.

Pal R.

Osteoporosis in the age of COVID-19.

Girgis CM, Clifton-Bligh RJ.

Letter To the Editor: [Our Response to COVID-19 as Endocrinologists and Diabetologists].

Masi D, Risi R, Gnessi L, Watanabe M, Mariani S, Lubrano C.

Letter to the Editor: Our Response to COVID-19 as Endocrinologists and Diabetologists.

Zhang B, Zhang S.

Salivary gland disease in the era of COVID-19 pandemic.

Soldatova L, Rassekh CH, Baloch ZW, Jalaly JB, Sedora-Roman NI, Loevner LL, Cognetti DM, Witt RL, Dulguerov P.

Thyroid surgery during COVID-19 pandemic: Principles and philosophies.

Shaha AR.

DPP4 inhibition: preventing SARS-CoV-2 infection and/or progression of COVID-19?

Strollo R, Pozzilli P.

COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency.

Isidori AM, Arnaldi G, Boscaro M, Falorni A, Giordano C, Giordano R, Pivonello R, Pofi R, Hasenmajer V, Venneri MA, Sbardella E, Simeoli C, Scaroni C, Lenzi A.

SARS-CoV-2 and DPP4 inhibition: is it time to pray for Janus Bifrons?

Pitocco D, Tartaglione L, Viti L, Di Leo M, Pontecorvi A, Caputo S.

Practical recommendations for the management of diabetes in patients with COVID-19.

Bornstein SR, Rubino F, Khunti K, Mingrone G, Hopkins D, Birkenfeld AL, Boehm B, Amiel S, Holt RI, Skyler JS, DeVries JH, Renard E, Eckel RH, Zimmet P, Alberti KG, Vidal J, Geloneze B, Chan JC, Ji L, Ludwig B.

Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection.

Isidori AM, Pofi R, Hasenmajer V, Lenzi A, Pivonello R.

Letter to the Editor in response to the article "COVID-19 and diabetes: Can DPP4 inhibition play a role?

Kokic Males V.

Response to COVID -19 and Diabetes: Can DPP4 Inhibition Play a Role? - GLP-1 Might Play One Too.

Morin N.

COVID-19 and diabetes: Is this association driven by the DPP4 receptor? Potential clinical and therapeutic implications.

Barchetta I, Gisella Cavallo M, Giorgio Baroni M.

Importance of metabolic health in the era of COVID-19.

Rebelos E, Moriconi D, Virdis A, Taddei S, Foschi D, Nannipieri M.

Managing People with Diabetes Fasting for Ramadan During the COVID-19 Pandemic: A South Asian Health Foundation Update.

Hanif S, Ali SN, Hassanein M, Khunti K, Hanif W.

Racial Variations in COVID-19 Deaths May Be Due to Androgen Receptor Genetic Variants Associated with Prostate Cancer and Androgenetic Alopecia. Are Anti-Androgens a Potential Treatment for COVID-19?

McCoy J, Wambier CG, Vano-Galvan S, Shapiro J, Sinclair R, Müller Ramos P, Washenik K, Andrade M, Herrera S, Goren A.

Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab.

Paoli D, Pallotti F, Colangelo S, Basilico F, Mazzuti L, Turriziani O, Antonelli G, Lenzi A, Lombardo F.

Age, frailty and diabetes - triple jeopardy for vulnerability to COVID-19 infection.

Sinclair AJ, Abdelhafiz AH.

How the andrological sector suffered from the dramatic Covid 19 outbreak in Italy: supportive initiatives of the Italian Association of Andrology (SIA).

Rizzo M, Liguori G, Verze P, Palumbo F, Cai T, Palmieri A.

Letter to the editor in response to article: "Clinical considerations for patients with diabetes in times of COVID-19 epidemic (Gupta et al.).

Hussain A, do Vale Moreira NC.

Letter to Editor Response to Covid-19 Endocrinology & Diabetology.

Nadolsky KZ.

COVID-19 and diabetes mellitus: what we know, how our patients should be treated now, and what should happen next.

Angelidi AM, Belanger MJ, Mantzoros CS.

COVID-19 and Diabetic Foot: Will the Lamp Burn Bright?

Papanas N, Papachristou S.

Case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: What should we have in mind during the COVID-19 pandemic?

Baretić M.

Letter to the Editor: "Our Response to COVID-19 as Endocrinologists and Diabetologists".

Kasuki L, Gadelha MR.

Obesity and SARS-CoV-2: a population to safeguard.

Watanabe M, Risi R, Tuccinardi D, Baquero CJ, Manfrini S, Gnessi L.

COVID-19 infection may cause ketosis and ketoacidosis.

Li J, Wang X, Chen J, Zuo X, Zhang H, Deng A.

[Recommendations on the identification and transfer of children with critical diabetes during the COVID-19 outbreak].

Subspecialty Group of Endocrinology and Metabolism, Society of Pediatrics, Chinese Medical Association.; Subspecialty Group of Endocrinology and Metabolism, Society of Pediatrics, Chinese Medical Doctor Association..

Diabetes self-management amid COVID-19 pandemic.

Banerjee M, Chakraborty S, Pal R.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic.

Cure E, Cumhur Cure M.

ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group.

Cortese S, Asherson P, Sonuga-Barke E, Banaschewski T, Brandeis D, Buitelaar J, Coghill D, Daley D, Danckaerts M, Dittmann RW, Doepfner M, Ferrin M, Hollis C, Holtmann M, Konofal E, Lecendreux M, Santosh P, Rothenberger A, Soutullo C, Steinhausen HC, Taylor E, Van der Oord S, et al.

Letter to the Editor: Our Response to COVID-19 as Endocrinologists and Diabetologists

Kobaly K, Mandel SJ, Cappola AR, Kim CS.

Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome.

Roncon L, Zuin M, Rigatelli G, Zuliani G.

COVID-19 and diabetes management: What should be considered?

Ceriello A, Stoian AP, Rizzo M.

ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection.

Barazzoni R, Bischoff SC, Breda J, Wickramasinghe K, Krznaric Z, Nitzan D, Pirlich M, Singer P; endorsed by the ESPEN Council..

Artificial Intelligence (AI) applications for COVID-19 pandemic.

Vaishya R, Javaid M, Khan IH, Haleem A.

Endocrinology in the time of COVID-19.

Arlt W, Dekkers OM, Leger J, Semple RK.

Androgen hazards with COVID-19.

Sharifi N, Ryan C.

Managing New-Onset Type 1 Diabetes During the COVID-19 Pandemic: Challenges and Opportunities.

Garg SK, Rodbard D, Hirsch IB, Forlenza GP.

The COVID-19 pandemics: shall we expect andrological consequences? A call for contributions to ANDROLOGY.

Simoni M, Hofmann MC.

A preliminary observation: male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severity.

Goren A, Vano-Galvan S, Wambier CG, McCoy J, Gomez-Zubiaur A, Moreno-Arrones OM, Shapiro J, Sinclair R, Gold MH, Kovacevic M, Mesinkovska NA, Goldust M, Washeni K.

COVID-19 outbreak and steroids administration: are patients treated for Sars-Cov-2 at risk of adrenal insufficiency?

Scaroni C, Armigliato M, Cannavò S.

What Is the Role of Angiotensin-Converting Enzyme 2 (ACE2) in COVID-19 Infection in Hypertensive Patients With Diabetes?

John TJ, John K.

Prediction of the number of deaths in India due to SARS-CoV-2 at 5-6 weeks.

Ghosal S, Sengupta S, Majumder M, Sinha B.

Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations.

Singh AK, Gupta R, Ghosh A, Misra A.

[Expert consensus on sleep study and non-invasive positive airway pressure therapy during the epidemic of coronavirus disease 2019].

Sleep Disorder Group of Chinese Thoracic Society.; Group of Sleep Disordered Breathing, the Committee of Respiratory Diseases of China Association of Medical Equipment..

Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications.

Drucker DJ.

Hyperglycemia, Hydroxychloroquine, and the COVID-19 Epidemic.

Brufsky A.

Impact of Nutrition and Diet on COVID-19 Infection and Implications for Kidney Health and Kidney Disease Management.

Kalantar-Zadeh K, Moore LW.

Is low sodium intake a risk factor for severe and fatal COVID-19 infection?

Post A, Dullaart RPF, Bakker SJL.

Covid-19 and cancer patients: Choosing wisely is the key.

Cannizzaro R, Puglisi F.

Care for diabetes with COVID-19: Advice from China.

Wang W, Lu J, Gu W, Zhang Y, Liu J, Ning G.

Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers.

Singh AK, Gupta R, Misra A.

COVID-19: From bench to bed side.

Singh A, Shaikh A, Singh R, Singh AK.

Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians.

Ghosh A, Gupta R, Misra A.

SARS-COV-2 infection is likely to be androgen mediated.

Wambier CG, Goren A.

Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?

Pal R, Bhadada SK.

COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology.

Puig-Domingo M, Marazuela M, Giustina A.

COVID-19 and diabetes: Knowledge in progress.

Hussain A, Bhowmik B, do Vale Moreira NC.

COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster.

Han Y, Jiang M, Xia D, He L, Lv X, Liao X, Meng J.

COVID-19 in patients with diabetes: risk factors that increase morbidity.

Klonoff DC, Umpierrez GE.

[SARS CoV-2/COVID-19: Evidence-Based Recommendation on Diagnosis and Therapy].

Bein B, Bachmann M, Huggett S, Wegermann P.

Commentary: COVID-19 and diabetes.

Villabona CV.

Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management.

Stoian AP, Banerjee Y, Rizvi AA, Rizzo M.

SARS-CoV-2 detection in patients with influenza-like illness.

Kong WH, Li Y, Peng MW, Kong DG, Yang XB, Wang L, Liu MQ.

COVID-19 Infection in italian people with diabetes: lessons learned for our future (an experience to be used).

Gentile S, Strollo F, Ceriello A.

The COVID-19 pandemic requires a unified global response.

Filetti S.

Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic.

Luzi L, Radaelli MG.

Doctors and healthcare workers at frontline of COVID 19 epidemic: Admiration, a pat on the back, and need for extreme caution.

Misra A.

Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc).

Gupta R, Misra A.

Cardiovascular disease and COVID-19.

Bansal M.

Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries.

Singh AK, Singh A, Shaikh A, Singh R, Misra A.

COVID-19 and diabetes.

Ma RCW, Holt RIG.

Hyperglycemia and the novel Covid-19 infection: Possible pathophysiologic mechanisms.

Ilias I, Zabuliene L.

The Importance of Diagnostic Testing during a Viral Pandemic: Early Lessons from Novel Coronavirus Disease (COVID-19).

Rosenthal PJ.

COVID-19, diabetes mellitus and ACE2: The conundrum.

Pal R, Bhansali A.

Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics.

Maddaloni E, Buzzetti R.

Diabetes is a risk factor for the progression and prognosis of COVID-19.

Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, Qin R, Wang H, Shen Y, Du K, Zhao L, Fan H, Luo S, Hu D.

Our Response to COVID-19 as Endocrinologists and Diabetologists.

Kaiser UB, Mirmira RG, Stewart PM.

COVID-19 Pandemic, Corona Viruses, and Diabetes Mellitus.

Muniyappa R, Gubbi S.

COVID-19 and diabetes: Can DPP4 inhibition play a role?

Iacobellis G.

Prevalence and impact of diabetes among people infected with SARS-CoV-2.

Fadini GP, Morieri ML, Longato E, Avogaro A.

Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?

[No authors listed]

Covid-19: diabetes clinicians set up social media account to help alleviate patients' fears.

Iacobucci G.

Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China.

Zhou J, Tan J.

Commentary: COVID-19 in patients with diabetes.

Hill MA, Mantzoros C, Sowers JR.

[The Management of Blood Glucose Should be Emphasized in the Treatment of COVID-19].

Ma WX, Ran XW.

All Feet On Deck-The Role of Podiatry During the COVID-19 Pandemic: Preventing hospitalizations in an overburdened healthcare system, reducing amputation and death in people with diabetes.

Rogers LC, Lavery LA, Joseph WS, Armstrong DG.

Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed.

Wang A, Zhao W, Xu Z, Gu J.

Clinical considerations for patients with diabetes in times of COVID-19 epidemic.

Gupta R, Ghosh A, Singh AK, Misra A.

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

Fang L, Karakiulakis G, Roth M.

Diabetes and COVID-19.

Bloomgarden ZT.

Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.

Lippi G, Plebani M.

Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China.

Yu F, Du L, Ojcius DM, Pan C, Jiang S.